Edit

NuMedii

http://numedii.com/

Last activity: 18.08.2022

Active

Categories: Artificial IntelligenceBioTechDataDrugHumanLabLifeTechnologyUniversity

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.

Likes

Followers

574

Followers

781

Website visits

2.5K /mo.

Mentions

Location: United States, California, San Mateo

Employees: 1-10

Phone: (650) 918-6363

Total raised: $3.5M

Founded date: 2008

Twitter

Facebook

Investors 2

Date	Name	Website
-	Life Scien...	lifescienc...
-	StartX	startx.com

Funding Rounds 1

Date	Series	Amount	Investors
26.06.2013	Series A	$3.5M	-

Mentions in press and media 24

Date	Title	Description
18.08.2022	Искусственный интеллект в медицине: сферы, технологии и перспективы	Искусственный интеллект, внедряемый в узкоспециальных областях, оказывается перспективнее более общих проектов, недостатки которых мы рассмотрели в предыдущей статье на примере беспилотных автомобилей. На этот раз разберем медицинские техно...
26.03.2018	This is how AI will shape drug discovery	An oft-quoted statistic is that it takes 12 years and almost $2 billion dollars to bring an average drug to market. That is the raison d’être for the biotech VC industry, which saw $10 billion of capital invested in startups in 2017 alone, ...
09.01.2018	Andy Slavitt: When it comes to AI, it is the best of times, worst of times story	“To some extent, [AI] is a best of times, worst of times story.” He noted that medtech advancements could lead to people using 3D bioprinting to get a new liver or use predictive analytics to figure out what is the right topic to focus on w...
14.02.2017	The opportunities and challenges of AI in health care	We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! When we asked dozens of venture capitalists where...
19.09.2015	Bursting The Top Three Myths To Get Your Healthcare Startup Funded	Michael Jin Contributor Michael Jin is a founding partner at TEEC Angel Fund. The evolution of the healthcare industry has brought forth innovative startup opportunities in the past few years. A few are actually helping to change the world....
04.11.2013	Big data, turbo-charged. Thompson Reuters & NuMedii partner to find new uses for old drugs	So far, three papers have been published showing the promise of the technology’s matchmaking abilities. In September, Stanford University researchers said a class of antidepressants showed activity in experimental models of small-cell lung ...
02.08.2013	For your daily fix of inspiration and insight, follow these 10 physician innovators on Twitter	Some of the best healthcare startup stories begin with a doctor. Frustrated by an inefficient procedure or lack of a good tool, he devises a solution to bring to the masses. If it seems like you’ve heard this story more and more recently, i...
27.06.2013	Stanford startup NuMedii raises $3.5M in Series A to grow big data for pharma platform	“NuMedii’s drug development approach is extremely capital efficient and is designed to be much more successful in bringing new therapeutics to patients. We are excited to have the backing of investors and advisors who have a track record of...
26.06.2013	NuMedii Receives $3.5M in Series A Funding	NuMedii, Inc., a Menlo Park, CA-based drug discovery company, received $3.5m in Series A funding. The round was led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation from Life Science Angels and others. In conj...
26.06.2013	NuMedii Receives $3.5M in Series A	PALO ALTO, CA, Firm that discovers and de-risks effective new drugs by translating its predictive Big Data technology, announced that it has received $3.5M in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partn...
07.02.2013	Meet The Next 10 Companies To Come Out Of StartX, Stanford’s Student Startup Accelerator	Stanford’s student startup accelerator, StartX, had its eighth demo day tonight in Palo Alto, showing off the latest class of 11 companies* to go through the program. The accelerator, which just raised another $400,000, has already had abou...
31.12.2012	Silicon Valley VCs predict 2013 trends: Space, robots, self-driving cars	As the year draws to an end, Silicon Valley investors are looking for the next wave of technology after social networking. VentureBeat spoke to a slew of the top players at well-known West Coast institutions — the founding team at Stanford ...
03.10.2012	Using data to find new drug-disease matches wins startup NuMedii its first pharma deal	The big data startup will use its predictive data platform to provide Aptalis with potential new therapeutic candidates, and New Jersey-based Aptalis will be responsible for the development and commercialization of the candidates it chooses...
07.09.2012	Stanford startups pitch earwax removal, blood-drawing robots and more at summer Demo Day	Watch live video from start x on Justin.tv Remember that post last week about robots taking over healthcare? StartX provides us with another example. Veebot LLC has developed a device that automates the most common vascular access procedure...
06.09.2012	StartX, The Startup Accelerator For Stanford Students, Kicks Off Its Summer 2012 Demo Day	StartX, the startup accelerator for companies founded by Stanford students, just kicked off Demo Day for its Summer 2012 startup class at AOL’s Silicon Valley headquarters in Palo Alto this evening. The non-profit program, which recently la...
29.03.2012	The Cloud Will Cure Cancer	Editor’s note: Mark Kaganovich is founder of SolveBio and a doctoral candidate in genetics at Stanford University. Follow him on Twitter @markkaganovich. Much ink has been spilled on the huge leaps in communications, social networking, and ...
06.01.2012	Top 10 science and clinical innovation trends: Looking forward to 2012	(Michael Knowles/Flickr) By Nancy Fliesler Here once again is Vector’s take on some exciting trends we’ve been watching in the pediatric health arena and what we expect to see more of this year. If you’ve got others to propose, scroll to th...
-	Stanford startups pitch earwax removal, blood-drawing robots and more at summer Demo Day	From medical devices to robots to big data for drug discovery, health-related startups presenting at last night’s StartX Demo Day pretty much ran the gamut. The nonprofit accelerator for Stanford University students and faculty showed off 1...
-	Using data to find new drug-disease matches wins startup NuMedii its first pharma deal	Pairing existing drugs with new disease applications, using not wet labs but computers, has landed a Stanford startup its first contract with a pharmaceutical company. NuMedii has signed its first product-focused deal with specialty pharmac...
-	For your daily fix of inspiration and insight, follow these 10 physician innovators on Twitter	Some of the best healthcare startup stories begin with a doctor. Frustrated by an inefficient procedure or lack of a good tool, he devises a solution to bring to the masses. If it seems like you’ve heard this story more and more recently, i...
-	Andy Slavitt: When it comes to AI, it is the best of times, worst of times story	Artificial intelligence is the kind of topic that brings out the inner geek in all of us. There is so much excitement about its potential applications and where it will have the greatest traction to the point where the conversation inevitab...
-	Big data, turbo-charged. Thompson Reuters & NuMedii partner to find new uses for old drugs	Thompson Reuters will lend some of its scientific and clinical data and analysis methods to power startup NuMedii’s mission to find new uses for old drugs through a new strategic partnership. Stanford University spinout NuMedii has develope...
-	This is how AI will shape drug discovery	As healthcare venture capitalists, we specialize in technologies that have the potential to transform large markets in healthcare. Earlier this year, we predicted that 2018 would be a year of venture and M&A activity across the pharma v...
-	Stanford startup NuMedii raises $3.5M in Series A to grow big data for pharma platform	NuMedii Inc. raised $3.5 million this week in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation by Life Science Angels and others. NuMedii raised this oversubscribed initial round to furt...

NuMedii

Investors 2

Funding Rounds 1

Mentions in press and media 24

Reviews 0